The child's brain is more malleable or plastic than that of adults and this accounts for the
ability of children to learn new skills quickly or recovery from brain injuries. Several …

Hypoxic-ischemic encephalopathy (HIE) is a leading cause of mortality and morbidity during
the perinatal period, and currently no therapeutic drug is available. Minocycline, an …

Neonatal hypoxic-ischaemic encephalopathy (HIE) is a serious condition; many survivors
develop neurological impairments, including cerebral palsy and intellectual disability …

Subcortical white matter (WM) is a frequent target of ischemic injury and extensive WM
lesions are important substrates of vascular cognitive impairment (VCI) in humans. However …

Goal Combinatorial therapy directed at both vascular and neurodegenerative aspects of
dementia may offer a promising strategy for treatment of dementia, which often has a …

Diesbetes acrophage migration inhibitory factor (Mlt) is rediscovered as a proinflammatory
cytokine and glucocorticoid-induced immunoregulator (1). We found that MIF was expressed …

Perinatal hypoxic ischemic encephalopathy (HIE) results in serious neurological dysfunction
and mortality. Clinical trials of multilineage-differentiating stress enduring cells (Muse cells) …

Apolipoprotein AV (apoA-V) is a recently discovered apolipoprotein that appears to have a
role in plasma triglyceride (TG) transport. We have developed an ELISA for apoA-V using …

This study aimed to investigate whether the administration of mononuclear cells derived
from human umbilical cord blood cells (UCBCs) could ameliorate hypoxic-ischemic brain …

Neonatal brain injury induced by stroke causes significant disability, including cerebral
palsy, and there is no effective therapy for stroke. Recently, mesenchymal stem cells (MSCs) …